References


  1. NHS Choices. Crohn’s Disease Causes. Available at: http://www.nhs.uk/Conditions/Crohns-disease/Pages/Causes.aspx. Last accessed: June 2017.Patient.info.
  2. Patient.Info. Crohn’s Disease Leaflet. Available at: http://patient.info/health/crohns-disease-leaflet. Last accessed: June 2017.
  3. Crohn’s & Colitis UK. Crohn’s Disease. Available from: http://www.crohnsandcolitis.org.uk/about-inflammatory-bowel-disease/croh.... Last accessed: June 2017.
  4. Centers for Disease Control and Prevention. What is inflammatory bowel disease? Available from: http://www.cdc.gov/ibd/what-is-ibd.htm. Last accessed: June 2017.
  5. Crohn’s & Colitis Foundation of America. What is Crohn’s Disease? Available from: www.ccfa.org/what-are-crohns-and-colitis/what-is-crohns-disease. Last accessed: June 2017.
  6. Lix, LM., et al. Inflamm Bowel Diseases 2008. 14(11):1575-1584.
  7. Bernklev, et al. Eur J of Gasto & Hep 2005. 17(10):1037-1045.
  8. Crohn’s & Colitis Foundation of America. IBD & Colorectal Cancer. Available from: http://www.ibdetermined.org/ibd-information/ibd-complications/colorectal-cancer.aspx. Last accessed: June 2017.
  9. Crohn’s & Colitis Foundation of America. IBD & Depression. Available from: http://www.ibdetermined.org/ibd-information/ibd-quality-of-life/ibd-depression.aspx. Last accessed: June 2017. 
  10. Becker, HM., et alCanadian Journal of Gastroenterology & Hepatology 2015. 29(2):77-84.
  11. Siegel, C. A. Current Opinion in Gastroenterology 2009. 25(4), 334–338.
  12. Allais, L., et al. Pathobiology 2016. 84(1):1-15
  13. Richman, E., and Rhodes, J. M. Aliment Pharmacol Ther 2008. 38: 1156–1171.
  14. Crohn’s & Colitis UK. Staying Well with IBD. Available from: http://s3-eu-west-1.amazonaws.com/files.crohnsandcolitis.org.uk/
    Publications/staying-well-with-IBD.pdf
    . Last accessed: June 2017.
  15. Mawdsley JE, Rampton DS. Gut 2005;54(10):1481-1491.
  16. Crohn’s & Colitis UK. Drugs Used in IBD. Available from: http://s3-eu-west-1.amazonaws.com/files.crohnsandcolitis.org.uk/
    Publications/biological-drugs.pdf
    . Last accessed: June 2017.
  17. Feagan B, et al. UEGW 2015: Abstract UEG15-LB-5668.
  18. Jowett SL., Seal CJ., Walfare MR. Am J Gastroenterol. 2001 Oct;96(10):2921-8.
  19. Sands B, et al. Ustekinumab Improves General Health Status and Disease-Specific Health Related Quality of Life of Patients with Moderate to Severe Crohn's Disease: Results from the UNITI and IMUNITI Phase 3 Clinical Trials. Gastroenterology, 150:4.
  20. The links provided are for education purposes only. No sponsorship or endorsement is implied.